Abstract |
Study investigated the ability of docosahexaenoic acid (DHA) alone and in combination with gamma-tocotrienol (γT3) to eliminate aldehyde dehydrogenase positive (ALDH+) cells and to inhibit mammosphere formation, biomarker and functional assay for tumor initiating cells ( TICs), respectively, in human triple negative breast cancer cells (TNBCs), and investigated possible mechanisms of action. DHA upregulated Src homology region 2 domain-containing protein tyrosine phosphatase-1 (SHP-1) protein levels and suppressed levels of phosphorylated signal transducer and activator of transcription-3 (pStat3) and its downstream mediators c-Myc, and cyclin D1. siRNA to SHP-1 enhanced the percentage of ALDH+ cells and Stat-3 signaling, as well as inhibited, in part, the ability of DHA to reduce the percentage of ALDH+ cells and Stat-3 signaling. γT3 alone and in combination with DHA reduced ALDH+ TNBCs, up-regulated SHP-1 protein levels, and suppressed Stat-3 signaling. Taken together, data demonstrate the anti- TIC potential of achievable concentrations of DHA alone as well as in combination with γT3.
|
Authors | Ailian Xiong, Weiping Yu, Yaobin Liu, Bob G Sanders, Kimberly Kline |
Journal | Molecular carcinogenesis
(Mol Carcinog)
Vol. 55
Issue 5
Pg. 420-30
(May 2016)
ISSN: 1098-2744 [Electronic] United States |
PMID | 25648304
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 Wiley Periodicals, Inc. |
Chemical References |
- Chromans
- STAT3 Transcription Factor
- STAT3 protein, human
- Vitamin E
- Docosahexaenoic Acids
- plastochromanol 8
- Aldehyde Dehydrogenase
- PTPN6 protein, human
- Protein Tyrosine Phosphatase, Non-Receptor Type 6
|
Topics |
- Aldehyde Dehydrogenase
(metabolism)
- Antineoplastic Combined Chemotherapy Protocols
- Cell Line, Tumor
- Chromans
(pharmacology)
- Docosahexaenoic Acids
(pharmacology)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Neoplastic Stem Cells
(drug effects, enzymology)
- Phosphorylation
(drug effects)
- Protein Tyrosine Phosphatase, Non-Receptor Type 6
(metabolism)
- STAT3 Transcription Factor
(metabolism)
- Signal Transduction
(drug effects)
- Triple Negative Breast Neoplasms
(enzymology, metabolism)
- Vitamin E
(analogs & derivatives, pharmacology)
|